Dopamine activation of endogenous cannabinoid signaling in dorsal striatum

A. Giuffrida, L. H. Parsons, T. M. Kerr, F. Rodríguez De Fonseca, M. Navarro, D. Piomelli

Resultado de la investigación: Articlerevisión exhaustiva

671 Citas (Scopus)

Resumen

We measured endogenous cannabinoid release in dorsal striatum of freely moving rats by microdialysis and gas chromatography/mass spectrometry. Neural activity stimulated the release of anandamide, but not of other endogenous cannabinoids such as 2-arachidonylglycerol. Moreover, anandamide release was increased eightfold over baseline after local administration of the D2-like (D2, D3, D4) dopamine receptor agonist quinpirole, a response that was prevented by the D2-like receptor antagonist raclopride. Administration of the D1-like (D1, D5) receptor agonist SKF38393 had no such effect. These results suggest that functional interactions between endocannabinoid and dopaminergic systems may contribute to striatal signaling. In agreement with this hypothesis, pretreatment with the cannabinoid antagonist SR141716A enhanced the stimulation of motor behavior elicited by systemic administration of quinpirole. The endocannabinoid system therefore may act as an inhibitory feedback mechanism countering dopamine-induced facilitation of motor activity.

Idioma originalEnglish (US)
Páginas (desde-hasta)358-363
Número de páginas6
PublicaciónNature Neuroscience
Volumen2
N.º4
DOI
EstadoPublished - abr. 1999
Publicado de forma externa

ASJC Scopus subject areas

  • Neuroscience(all)

Huella

Profundice en los temas de investigación de 'Dopamine activation of endogenous cannabinoid signaling in dorsal striatum'. En conjunto forman una huella única.

Citar esto